{
    "xml": "<topic id=\"PHP510\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/beclometasone-dipropionate\" basename=\"beclometasone-dipropionate\" title=\"BECLOMETASONE DIPROPIONATE\">\n<title>BECLOMETASONE DIPROPIONATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_495\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/beclometasone\">Beclometasone</xref>\n</p>\n<data name=\"vtmid\">1389007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_832374428\" title=\"Corticosteroids\">Corticosteroids</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34650\" title=\"CORTICOSTEROIDS (INHALED)\" namespace=\"/drug-classes/corticosteroids-inhaled\">CORTICOSTEROIDS (INHALED)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" namespace=\"/drug-classes/corticosteroids-systemic\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34648\" title=\"CORTICOSTEROIDS (INTRANASAL)\" namespace=\"/drug-classes/corticosteroids-intranasal\">CORTICOSTEROIDS (INTRANASAL)</xref>\n</data>\r\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34550\" title=\"CORTICOSTEROIDS (TOPICAL)\" namespace=\"/drug-classes/corticosteroids-topical\">CORTICOSTEROIDS (TOPICAL)</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">Beclomethasone dipropionate</p>\r\n</body>\n<topic id=\"PHP38035\" outputclass=\"indicationsAndDose\" rev=\"1.84\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Management of oral ulceration</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By buccal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>50&#8211;100&#8239;micrograms twice daily, use inhaler device to spray dose on to the oral mucosa.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of powder</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 5&#8211;11 years</p>\n<p>100&#8211;200&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>200&#8211;400&#8239;micrograms twice daily; increased if necessary up to 800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8211;400&#8239;micrograms twice daily; increased if necessary up to 800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis and treatment of allergic and vasomotor rhinitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;17 years</p>\n<p>100&#8239;micrograms twice daily, dose to be administered into each nostril, reduced to 50&#8239;micrograms twice daily, dose to be administered into each nostril, dose to be reduced when symptoms controlled; maximum 400&#8239;micrograms per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>100&#8239;micrograms twice daily, dose to be administered into each nostril, reduced to 50&#8239;micrograms twice daily, dose to be administered into each nostril, dose to be reduced when symptoms controlled; maximum 400&#8239;micrograms per day.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids</p>\n<p outputclass=\"therapeuticIndication\">Psoriasis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">To the skin</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>Apply 1&#8211;2 times a day, thin layer to be applied.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Apply 1&#8211;2 times a day, thin layer to be applied.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct to aminosalicylates in acute mild to moderate ulcerative colitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg daily maximum duration of treatment of 4 weeks, dose to be taken in the morning.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>Dose adjustments may be required for some inhaler devices, see under individual preparations.</p>\n</section>\n<section outputclass=\"potency\">\n<title>Potency</title>\n<p>Beclometasone dipropionate cream and ointment 0.025%: potent.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP37973\" outputclass=\"unlicensedUse\" rev=\"1.20\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">topical</ph> use in children</p>\n<p>Not licensed for use in children under 1 year.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral (topical)</ph> use</p>\n<p>Use of soluble tablets and inhaler unlicensed in oral ulceration.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> in children</p>\n<p>\n<i>Easyhaler</i>\n<tm tmtype=\"reg\"/>\n<i>Beclometasone Dipropionate</i> is not licensed for use in children under 18 years.</p>\n<p>\n<i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/> -200 and -250 are not licensed for use in children under 12 years.</p>\n<p>\n<i>Qvar</i>\n<tm tmtype=\"reg\"/> is not licensed for use in children under 12 years.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38055\" outputclass=\"importantSafetyInformation\" rev=\"1.10\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p outputclass=\"title\">MHRA/CHM advice (July 2008)</p>\n<p>Beclometasone dipropionate CFC-free pressurised metered-dose inhalers (<i>Qvar</i>\n<tm tmtype=\"reg\"/> and <i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/>) are <b>not</b> interchangeable and should be prescribed by brand name; <i>Qvar</i>\n<tm tmtype=\"reg\"/> has extra-fine particles, is more potent than traditional beclometasone dipropionate CFC-containing inhalers, and is approximately twice as potent as <i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> in adults</p>\n<p outputclass=\"title\">MHRA/CHM advice (July 2008)</p>\n<p>\n<i>Fostair</i>\n<tm tmtype=\"reg\"/> is a combination beclometasone dipropionate and formoterol fumarate CFC-free pressurised metered-dose inhaler; <i>Fostair</i>\n<tm tmtype=\"reg\"/> has extra-fine particles and is more potent than traditional beclometasone dipropionate CFC-free inhalers.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP37993\" outputclass=\"sideEffects\" rev=\"1.19\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"specificSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"sideEffect\">constipation</ph> (in adults); <ph outputclass=\"sideEffect\">drowsiness</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38043\" outputclass=\"hepaticImpairment\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\n<p>Manufacturer advises avoid in severe impairment&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP59545\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.25\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Safety and efficacy not established for use in children.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>The MHRA has advised (July 2008) that beclometasone dipropionate CFC-free inhalers should be prescribed by brand name.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP38012\" outputclass=\"patientAndCarerAdvice\" rev=\"1.27\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\r\n</p>\r\n<p>Steroid card should be issued with high doses of inhaled beclometasone dipropionate.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph> in children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Beclometasone for asthma prevention (prophylaxis)</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/beclometasone-inhaler-asthma-prevention-prophylaxis-0\">www.medicinesforchildren.org.uk/beclometasone-inhaler-asthma-prevention-prophylaxis-0</xref>\n</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP35908\" outputclass=\"professionSpecificInformation\" rev=\"1.12\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Profession specific information</title>\n<body>\n<section outputclass=\"dentalPractitionersFormulary\">\n<title>Dental practitioners' formulary</title>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>\n<i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/> 50&#8239;micrograms/metered inhalation may be prescribed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35904\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.6\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intranasal</ph> use in adults</p>\n<p>Preparations of beclometasone dipropionate can be sold to the public for nasal administration as a nasal spray if supplied for the prevention and treatment of allergic rhinitis in adults over 18 years subject to max. single dose of 100&#8239;micrograms per nostril, max. daily dose of 200&#8239;micrograms per nostril for max. 3 months, and a pack size of 20&#8239;mg.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP510-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/beclometasone-dipropionate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: cream, ointment</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76324\" title=\"Modified-release tablet\" namespace=\"/drugs/beclometasone-dipropionate/modified-release-tablet\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76241\" title=\"Pressurised inhalation\" namespace=\"/drugs/beclometasone-dipropionate/pressurised-inhalation\">Pressurised inhalation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76160\" title=\"Inhalation powder\" namespace=\"/drugs/beclometasone-dipropionate/inhalation-powder\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76408\" title=\"Cream\" namespace=\"/drugs/beclometasone-dipropionate/cream\">Cream</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76477\" title=\"Ointment\" namespace=\"/drugs/beclometasone-dipropionate/ointment\">Ointment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76097\" title=\"Spray\" namespace=\"/drugs/beclometasone-dipropionate/spray\">Spray</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85578\" namespace=\"/drugs/beclometasone-with-formoterol\" title=\"BECLOMETASONE WITH FORMOTEROL\" count=\"1\" rel=\"backlink\">BECLOMETASONE WITH FORMOTEROL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78288\" namespace=\"/treatment-summaries/glucocorticoid-therapy\" title=\"Glucocorticoid therapy\" count=\"1\" rel=\"backlink\">Glucocorticoid therapy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78316\" namespace=\"/treatment-summaries/inflammatory-bowel-disease\" title=\"Inflammatory bowel disease\" count=\"2\" rel=\"backlink\">Inflammatory bowel disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78318\" namespace=\"/treatment-summaries/airways-disease-use-of-corticosteroids\" title=\"Airways disease, use of corticosteroids\" count=\"2\" rel=\"backlink\">Airways disease, use of corticosteroids</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78365\" namespace=\"/treatment-summaries/oral-ulceration-and-inflammation\" title=\"Oral ulceration and inflammation\" count=\"1\" rel=\"backlink\">Oral ulceration and inflammation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78495\" namespace=\"/treatment-summaries/nose\" title=\"Nose\" count=\"1\" rel=\"backlink\">Nose</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_495\" namespace=\"/interactions/list-of-drug-interactions/corticosteroids/beclometasone\" title=\"Beclometasone\" count=\"1\" rel=\"link\">Beclometasone</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34650\" namespace=\"/drug-classes/corticosteroids-inhaled\" title=\"CORTICOSTEROIDS (INHALED)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (INHALED)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34623\" namespace=\"/drug-classes/corticosteroids-systemic\" title=\"CORTICOSTEROIDS (SYSTEMIC)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (SYSTEMIC)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34648\" namespace=\"/drug-classes/corticosteroids-intranasal\" title=\"CORTICOSTEROIDS (INTRANASAL)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (INTRANASAL)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34550\" namespace=\"/drug-classes/corticosteroids-topical\" title=\"CORTICOSTEROIDS (TOPICAL)\" count=\"1\" rel=\"link\">CORTICOSTEROIDS (TOPICAL)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76324\" namespace=\"/drugs/beclometasone-dipropionate/modified-release-tablet\" title=\"Modified-release tablet\" count=\"1\" rel=\"link\">Modified-release tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76241\" namespace=\"/drugs/beclometasone-dipropionate/pressurised-inhalation\" title=\"Pressurised inhalation\" count=\"1\" rel=\"link\">Pressurised inhalation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76160\" namespace=\"/drugs/beclometasone-dipropionate/inhalation-powder\" title=\"Inhalation powder\" count=\"1\" rel=\"link\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76408\" namespace=\"/drugs/beclometasone-dipropionate/cream\" title=\"Cream\" count=\"1\" rel=\"link\">Cream</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76477\" namespace=\"/drugs/beclometasone-dipropionate/ointment\" title=\"Ointment\" count=\"1\" rel=\"link\">Ointment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76097\" namespace=\"/drugs/beclometasone-dipropionate/spray\" title=\"Spray\" count=\"1\" rel=\"link\">Spray</xref>\n</links>\n</topic>",
    "id": "PHP510",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/beclometasone-dipropionate",
    "basename": "beclometasone-dipropionate",
    "title": "BECLOMETASONE DIPROPIONATE",
    "interactants": [
        {
            "id": "bnf_int_495",
            "label": "Beclometasone"
        }
    ],
    "vtmid": "1389007",
    "drugClassification": [
        "Corticosteroids"
    ],
    "inheritsFromClass": [
        "CORTICOSTEROIDS (INHALED)",
        "CORTICOSTEROIDS (SYSTEMIC)",
        "CORTICOSTEROIDS (INTRANASAL)",
        "CORTICOSTEROIDS (TOPICAL)"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Beclomethasone dipropionate"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Management of oral ulceration",
                        "html": "Management of oral ulceration"
                    }
                ],
                "specificity": {
                    "routes": [
                        "buccal administration"
                    ],
                    "textContent": "By buccal administration",
                    "html": "By buccal administration"
                },
                "adult": [
                    {
                        "textContent": "50&#8211;100 micrograms twice daily, use inhaler device to spray dose on to the oral mucosa.",
                        "html": "<p>50&#8211;100&#8239;micrograms twice daily, use inhaler device to spray dose on to the oral mucosa.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of asthma",
                        "html": "Prophylaxis of asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of powder"
                    ],
                    "textContent": "By inhalation of powder",
                    "html": "By inhalation of powder"
                },
                "child": [
                    {
                        "textContent": "100&#8211;200 micrograms twice daily, dose to be adjusted as necessary.",
                        "html": "<p>100&#8211;200&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>",
                        "ageGroup": "5&#8211;11 years"
                    },
                    {
                        "textContent": "200&#8211;400 micrograms twice daily; increased if necessary up to 800 micrograms twice daily, dose to be adjusted as necessary.",
                        "html": "<p>200&#8211;400&#8239;micrograms twice daily; increased if necessary up to 800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "200&#8211;400 micrograms twice daily; increased if necessary up to 800 micrograms twice daily, dose to be adjusted as necessary.",
                        "html": "<p>200&#8211;400&#8239;micrograms twice daily; increased if necessary up to 800&#8239;micrograms twice daily, dose to be adjusted as necessary.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis and treatment of allergic and vasomotor rhinitis",
                        "html": "Prophylaxis and treatment of allergic and vasomotor rhinitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "child": [
                    {
                        "textContent": "100 micrograms twice daily, dose to be administered into each nostril, reduced to 50 micrograms twice daily, dose to be administered into each nostril, dose to be reduced when symptoms controlled; maximum 400 micrograms per day.",
                        "html": "<p>100&#8239;micrograms twice daily, dose to be administered into each nostril, reduced to 50&#8239;micrograms twice daily, dose to be administered into each nostril, dose to be reduced when symptoms controlled; maximum 400&#8239;micrograms per day.</p>",
                        "ageGroup": "6&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "100 micrograms twice daily, dose to be administered into each nostril, reduced to 50 micrograms twice daily, dose to be administered into each nostril, dose to be reduced when symptoms controlled; maximum 400 micrograms per day.",
                        "html": "<p>100&#8239;micrograms twice daily, dose to be administered into each nostril, reduced to 50&#8239;micrograms twice daily, dose to be administered into each nostril, dose to be reduced when symptoms controlled; maximum 400&#8239;micrograms per day.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids",
                        "html": "Severe inflammatory skin disorders such as eczemas unresponsive to less potent corticosteroids"
                    },
                    {
                        "textContent": "Psoriasis",
                        "html": "Psoriasis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "To the skin"
                    ],
                    "textContent": "To the skin",
                    "html": "To the skin"
                },
                "child": [
                    {
                        "textContent": "Apply 1&#8211;2 times a day, thin layer to be applied.",
                        "html": "<p>Apply 1&#8211;2 times a day, thin layer to be applied.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "Apply 1&#8211;2 times a day, thin layer to be applied.",
                        "html": "<p>Apply 1&#8211;2 times a day, thin layer to be applied.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunct to aminosalicylates in acute mild to moderate ulcerative colitis",
                        "html": "Adjunct to aminosalicylates in acute mild to moderate ulcerative colitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5 mg daily maximum duration of treatment of 4 weeks, dose to be taken in the morning.",
                        "html": "<p>5&#8239;mg daily maximum duration of treatment of 4 weeks, dose to be taken in the morning.</p>"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Dose adjustments may be required for some inhaler devices, see under individual preparations.",
                "html": "<p>Dose adjustments may be required for some inhaler devices, see under individual preparations.</p>"
            }
        ],
        "potency": [
            {
                "type": "potency",
                "title": "Potency",
                "textContent": "Beclometasone dipropionate cream and ointment 0.025%: potent.",
                "html": "<p>Beclometasone dipropionate cream and ointment 0.025%: potent.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With topical use in children",
                    "html": "With <ph outputclass=\"route\">topical</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "topical"
                    ]
                },
                "textContent": "Not licensed for use in children under 1 year.",
                "html": "<p>Not licensed for use in children under 1 year.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With oral (topical) use",
                    "html": "With <ph outputclass=\"route\">oral (topical)</ph> use",
                    "routes": [
                        "oral (topical)"
                    ]
                },
                "textContent": "Use of soluble tablets and inhaler unlicensed in oral ulceration.",
                "html": "<p>Use of soluble tablets and inhaler unlicensed in oral ulceration.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "When used by inhalation in children",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Easyhaler Beclometasone Dipropionate is not licensed for use in children under 18 years.\n\nClenil Modulite -200 and -250 are not licensed for use in children under 12 years.\n\nQvar is not licensed for use in children under 12 years.",
                "html": "<p>\n<i>Easyhaler</i>\n<tm tmtype=\"reg\"/>\n<i>Beclometasone Dipropionate</i> is not licensed for use in children under 18 years.</p><p>\n<i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/> -200 and -250 are not licensed for use in children under 12 years.</p><p>\n<i>Qvar</i>\n<tm tmtype=\"reg\"/> is not licensed for use in children under 12 years.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "title": "MHRA/CHM advice (July 2008)",
                "textContent": "Beclometasone dipropionate CFC-free pressurised metered-dose inhalers (Qvar and Clenil Modulite ) are not interchangeable and should be prescribed by brand name; Qvar has extra-fine particles, is more potent than traditional beclometasone dipropionate CFC-containing inhalers, and is approximately twice as potent as Clenil Modulite .",
                "html": "<p>Beclometasone dipropionate CFC-free pressurised metered-dose inhalers (<i>Qvar</i>\n<tm tmtype=\"reg\"/> and <i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/>) are <b>not</b> interchangeable and should be prescribed by brand name; <i>Qvar</i>\n<tm tmtype=\"reg\"/> has extra-fine particles, is more potent than traditional beclometasone dipropionate CFC-containing inhalers, and is approximately twice as potent as <i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/>.</p>"
            },
            {
                "type": "importantSafetyInformation",
                "specificity": {
                    "textContent": "When used by inhalation in adults",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph> in adults",
                    "patientType": "adults",
                    "routes": [
                        "inhalation"
                    ]
                },
                "title": "MHRA/CHM advice (July 2008)",
                "textContent": "Fostair is a combination beclometasone dipropionate and formoterol fumarate CFC-free pressurised metered-dose inhaler; Fostair has extra-fine particles and is more potent than traditional beclometasone dipropionate CFC-free inhalers.",
                "html": "<p>\n<i>Fostair</i>\n<tm tmtype=\"reg\"/> is a combination beclometasone dipropionate and formoterol fumarate CFC-free pressurised metered-dose inhaler; <i>Fostair</i>\n<tm tmtype=\"reg\"/> has extra-fine particles and is more potent than traditional beclometasone dipropionate CFC-free inhalers.</p>"
            }
        ]
    },
    "sideEffects": {
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "constipation in adults",
                        "html": "constipation in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "drowsiness in adults",
                        "html": "drowsiness in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ],
                            "patientType": "adults"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Manufacturer advises avoid in severe impairment&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid in severe impairment&#8212;no information available.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Safety and efficacy not established for use in children.",
                "html": "<p>Safety and efficacy not established for use in children.</p>"
            },
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "The MHRA has advised (July 2008) that beclometasone dipropionate CFC-free inhalers should be prescribed by brand name.",
                "html": "<p>The MHRA has advised (July 2008) that beclometasone dipropionate CFC-free inhalers should be prescribed by brand name.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Steroid card should be issued with high doses of inhaled beclometasone dipropionate.",
                "html": "<p>Steroid card should be issued with high doses of inhaled beclometasone dipropionate.</p>"
            },
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/beclometasone-inhaler-asthma-prevention-prophylaxis-0",
                        "label": "www.medicinesforchildren.org.uk/beclometasone-inhaler-asthma-prevention-prophylaxis-0"
                    }
                ],
                "specificity": {
                    "textContent": "When used by inhalation in children",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph> in children",
                    "patientType": "children",
                    "routes": [
                        "inhalation"
                    ]
                },
                "title": "Medicines for Children leaflet: Beclometasone for asthma prevention (prophylaxis)",
                "textContent": "www.medicinesforchildren.org.uk/beclometasone-inhaler-asthma-prevention-prophylaxis-0",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/beclometasone-inhaler-asthma-prevention-prophylaxis-0\">www.medicinesforchildren.org.uk/beclometasone-inhaler-asthma-prevention-prophylaxis-0</xref>\n</p>"
            }
        ]
    },
    "professionSpecificInformation": {
        "dentalPractitionersFormulary": [
            {
                "type": "dentalPractitionersFormulary",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "Clenil Modulite 50 micrograms/metered inhalation may be prescribed.",
                "html": "<p>\n<i>Clenil Modulite</i>\n<tm tmtype=\"reg\"/> 50&#8239;micrograms/metered inhalation may be prescribed.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "specificity": {
                    "textContent": "With intranasal use in adults",
                    "html": "With <ph outputclass=\"route\">intranasal</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intranasal"
                    ]
                },
                "textContent": "Preparations of beclometasone dipropionate can be sold to the public for nasal administration as a nasal spray if supplied for the prevention and treatment of allergic rhinitis in adults over 18 years subject to max. single dose of 100 micrograms per nostril, max. daily dose of 200 micrograms per nostril for max. 3 months, and a pack size of 20 mg.",
                "html": "<p>Preparations of beclometasone dipropionate can be sold to the public for nasal administration as a nasal spray if supplied for the prevention and treatment of allergic rhinitis in adults over 18 years subject to max. single dose of 100&#8239;micrograms per nostril, max. daily dose of 200&#8239;micrograms per nostril for max. 3 months, and a pack size of 20&#8239;mg.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "cream",
                "ointment"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76324",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76241",
                "label": "Pressurised inhalation",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76160",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76408",
                "label": "Cream",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76477",
                "label": "Ointment",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76097",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85578",
                "label": "BECLOMETASONE WITH FORMOTEROL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78288",
                "label": "Glucocorticoid therapy",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78316",
                "label": "Inflammatory bowel disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78318",
                "label": "Airways disease, use of corticosteroids",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78365",
                "label": "Oral ulceration and inflammation",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78495",
                "label": "Nose",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_495",
                "label": "Beclometasone",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34650",
                "label": "CORTICOSTEROIDS (INHALED)",
                "type": "drugClass"
            },
            {
                "id": "PHP34623",
                "label": "CORTICOSTEROIDS (SYSTEMIC)",
                "type": "drugClass"
            },
            {
                "id": "PHP34648",
                "label": "CORTICOSTEROIDS (INTRANASAL)",
                "type": "drugClass"
            },
            {
                "id": "PHP34550",
                "label": "CORTICOSTEROIDS (TOPICAL)",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76324",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76241",
                "label": "Pressurised inhalation",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76160",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76408",
                "label": "Cream",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76477",
                "label": "Ointment",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76097",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    }
}